NCT05395052 2023-09-21FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid TumorsFate TherapeuticsPhase 1 Terminated5 enrolled
NCT01384253 2016-09-30Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio ImmunotherapyOrano Med LLCPhase 1 Completed18 enrolled
NCT00004074 2013-02-28Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuNational Cancer Institute (NCI)Phase 1 Completed15 enrolled
NCT00005842 2013-02-11Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerNational Cancer Institute (NCI)Phase 1 Completed24 enrolled